Past research: Cell labeling for improved MRI contrast through fabrication of polydimethylsiloxane (PDMS) nanoemulsions, with a focus on neural stem cells.
Past research: Obtaining prognostic information non-invasively using MRI techniques at early stages of traumatic brain injury and brain tumor. Development of image processing algorithms in MATLAB for quantitative analysis of MRI parametric maps and fiber tracking using diffusion tensor imaging (DTI) technique.
B.S.E. Biomedical Engineering, Arizona State University, 2016
Past research: Creating tumor spheroids in order to test hypoxia sensitive MRI contrast agents. Testing of dual modality siloxane based nanoemulsions loaded with Nile red, which work as both MRI and fluorescence probes for cancer therapeutics and diagnostics.
Past research; Time-dependent DCE-MRI data to quantify the perfusive properties of tumorous tissue
Past research: Characterizing cytotoxic effects of cyclophosphamide on prostate cancer cells at various doses and levels of tumor oxygenation.
Past research: Generating nanoparticles for use as MR contrast agents.
Past research: Focused on characterizing the OMDSO molecule and assessing its usefulness as a pO2 reporter molecule.
Ph.D. Biomolecular Science, Korea Institute of Science & Technology (KIST), Seoul, South Korea.
M.S. Biochemistry, Sri Krishnadevaraya University, Kurnool, India
B.S. Biochemistry, Sri Venkateswara University, Kadapa, India
Research Tech in Dr. Kodibagkar’s lab. Focused on detecting the biomarkers for hypoxia in tumor sections by Immunofluorescence and preparation of nanoemulsions formulations.